7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:27028343 | ||||
Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
pmid:27016924 | ||||
pmid:27016890 | ||||
pmid:27015557 | ||||
Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
pmid:26999703 | ||||
pmid:26991325 | ||||
Kats A et al. | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. | 2016 | J. Cell. Mol. Med. | pmid:26987561 |
pmid:26983475 | ||||
pmid:26982319 | ||||
pmid:26975539 | ||||
Moran CS et al. | Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. | 2016 | Arterioscler. Thromb. Vasc. Biol. | pmid:26966276 |
pmid:26956843 | ||||
pmid:26955837 | ||||
Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
pmid:26946239 | ||||
pmid:26945169 | ||||
pmid:26942563 | ||||
Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
pmid:26936893 | ||||
Kainuma S et al. | Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. | 2016 | Mol Med Rep | pmid:26935864 |
pmid:26926024 | ||||
pmid:26926023 | ||||
pmid:26924459 | ||||
pmid:26923849 | ||||
Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
pmid:26909563 | ||||
Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
pmid:26899523 | ||||
pmid:26896745 | ||||
pmid:26894505 | ||||
Li G et al. | Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. | 2015 | Int J Clin Exp Pathol | pmid:26884838 |
Stuss M et al. | Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2016 | Endokrynol Pol | pmid:26884284 |
pmid:26874038 | ||||
pmid:26869171 | ||||
pmid:26862884 | ||||
pmid:26856585 | ||||
pmid:26850415 | ||||
pmid:26849824 | ||||
pmid:26847856 | ||||
Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
pmid:26825871 | ||||
pmid:26825553 | ||||
pmid:26821332 | ||||
Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
pmid:26806398 | ||||
pmid:26798969 | ||||
Bumdelger B et al. | Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. | 2016 | PLoS ONE | pmid:26783750 |
Li B et al. | Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. | 2015 | Genet. Mol. Res. | pmid:26782591 |
Owen S et al. | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. | 2016 | Int. J. Oncol. | pmid:26781475 |
Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
pmid:26773114 | ||||
pmid:26771189 | ||||
pmid:26768749 | ||||
Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
pmid:26751719 | ||||
Theodoro LH et al. | Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. | 2016 | J. Periodont. Res. | pmid:26750739 |
pmid:26744072 | ||||
pmid:26743491 | ||||
Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
Kobayashi Y et al. | Regulation of bone metabolism by Wnt signals. | 2016 | J. Biochem. | pmid:26711238 |
pmid:26694734 | ||||
pmid:26691295 | ||||
Chen Z et al. | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. | 2016 | Int. J. Mol. Med. | pmid:26677102 |
pmid:26672708 | ||||
Zang L et al. | The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. | 2015 | Sci Rep | pmid:26671549 |
Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
Liu W et al. | Polymorphisms in three genes are associated with hemorrhagic stroke. | 2015 | Brain Behav | pmid:26664786 |
Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
pmid:26648171 | ||||
Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
pmid:26647458 | ||||
Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
Widschwendter M et al. | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629528 |
Rachner TD and Rauner M | RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629502 |
Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
pmid:26624862 | ||||
Miao Q et al. | Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. | 2015 | Int J Clin Exp Pathol | pmid:26617755 |
pmid:26609698 | ||||
Goswami S and Sharma-Walia N | Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. | 2015 | BMC Cancer | pmid:26608463 |
pmid:26595513 | ||||
pmid:26588909 | ||||
pmid:26584851 | ||||
Alam I et al. | Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. | 2016 | Endocrinology | pmid:26584014 |
pmid:26581047 | ||||
Mrozikiewicz-Rakowska B et al. | Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. | 2015 | J. Physiol. Pharmacol. | pmid:26579581 |
Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
pmid:26573557 | ||||
Mitchell JA et al. | Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. | 2016 | J. Bone Miner. Res. | pmid:26572781 |
pmid:26572759 | ||||
Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
Schiro A et al. | Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. | 2015 | Sci Rep | pmid:26564003 |